| 标题 |
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:Amer M. Zeidan; Kiyoshi Ando; Odile Beyne Rauzy; Mehmet Turgut; Ming‐Chung Wang; et al 出版日期:2023-12-05 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)